Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
The present invention is related to the use of topical formulations that contain epidermal growth factor (EGF) encapsulated in or associated to deformable or conventional liposomes to be applied on the surface of and around chronic ischemic skin lesions. The formulations of the present invention, in...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention is related to the use of topical formulations that contain epidermal growth factor (EGF) encapsulated in or associated to deformable or conventional liposomes to be applied on the surface of and around chronic ischemic skin lesions. The formulations of the present invention, in contrast with the previous art, are useful because they provide a high bioavailability of EGF in the tissue deep below the lesions and for preventing diabetic foot amputation. |
---|---|
AbstractList | The present invention is related to the use of topical formulations that contain epidermal growth factor (EGF) encapsulated in or associated to deformable or conventional liposomes to be applied on the surface of and around chronic ischemic skin lesions. The formulations of the present invention, in contrast with the previous art, are useful because they provide a high bioavailability of EGF in the tissue deep below the lesions and for preventing diabetic foot amputation. |
Author | BETANCOURT RODRIQUEZ BLAS YAMIR PAEZ MEIRELES ROLANDO PUPO ESCALONA ELDER BERLANGA ACOSTA JORGE AMADOR |
Author_xml | – fullname: PUPO ESCALONA ELDER – fullname: BETANCOURT RODRIQUEZ BLAS YAMIR – fullname: BERLANGA ACOSTA JORGE AMADOR – fullname: PAEZ MEIRELES ROLANDO |
BookMark | eNqNjDsOwjAQBVNAwe8OSwcFEiQoPYoSqKigjhZnHSzFXste4PoYxAGo3jxpNNNs5NjRJLPXSMAaEIS9UTiAYus5GjHsEjtB44zrgbzpKNgk9IFfcgeNSjjAqj42a9CJOoM3EqPSYQG0_iH4rfhAT3IfnGdjjUOkxW9n2bKpL9VpQ55bih4VOZK2Ou-2-zIvyiI_FP84b5liQ6U |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | CN104623632A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN104623632A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:04:08 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN104623632A3 |
Notes | Application Number: CN201510005113 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150520&DB=EPODOC&CC=CN&NR=104623632A |
ParticipantIDs | epo_espacenet_CN104623632A |
PublicationCentury | 2000 |
PublicationDate | 20150520 |
PublicationDateYYYYMMDD | 2015-05-20 |
PublicationDate_xml | – month: 05 year: 2015 text: 20150520 day: 20 |
PublicationDecade | 2010 |
PublicationYear | 2015 |
RelatedCompanies | CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA |
RelatedCompanies_xml | – name: CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA |
Score | 2.9832346 |
Snippet | The present invention is related to the use of topical formulations that contain epidermal growth factor (EGF) encapsulated in or associated to deformable or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150520&DB=EPODOC&locale=&CC=CN&NR=104623632A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVdH6YAQJegg2zaaPQxG7SSyCaZFWeivZdKMVTYKN-Ped3abWi972AcvuwLxn5wO4mLZFyxFTx5TCESarR21TSCsyGWNxHMWkcKTu9hk0eiN2P3bGJXhd_oXRfUK_dHNE4qiI-D3X8jpbBbFcXVs5vxYzWkpv_GHHNQrv2FKwbDXD7Xa8Qd_tc4PzDg-M4FGB3JKib9j12zVYJzO6qbjBe-qqXynZb5Xi78DGgE5L8l0oyaQCW3yJvFaBzYci4U3Dgvfme_A-mktMYwwxTzNFWlTl4EXNFaqS8wXYA0oF-kry9g2fycfOX3CBqYOX3p1_hWSk4iLgOotokuYYKlwH_WbMioZOabIP57435D2T7j35IdKEB6sn2gdQTtJEHgLaDTJIprasSSaZ1W6FLG7aJBxDYUfkKYkjqP59TvW_zWPYVgRXmfR67QTK-cenPCUFnYszTdlvGtiW-g |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD5BNOKbokbxVhOz6MMisI7LAzHSbaLCIAYMb2QdnWJ0W6TGv-9pGeqLvvWSNO1Jzv30fABn0yZv2Hxqm4Lb3KTVsGlyUQlNSmkUhREqHKG7ffq1zojeje1xDl6Wf2F0n9BP3RwROSpEfpdaXqc_QSxH11bOL_kMl5Irb9hyjMw7rihYtrLhtFvuoO_0mcFYi_mG_6BAblHR16zq9QqsooldV9zgPrbVr5T0t0rxNmFtgKfFcgtyIi5CgS2R14qw3ssS3jjMeG--DW-juSBJRAIik1SRlqhy8KzmiqiS8wXYAxEK9BXl7St5Qh9bPpMFpg45d2-8C4JGKlkEXGchThJJAoXroN9M0qyhUxLvwKnnDlnHxHtPvok0Yf7PE61dyMdJLPaAWDU0SKaWKAsqaKXZCGhUt1A4BtwK0VPi-1D6-5zSf5snUOgMe91J99a_P4ANRXyVVa-WDyEv3z_EESpryY81lb8AXL2Z7Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+a+topical+composition+containing+epidermal+growth+factor+%28EGF%29+for+diabetic+foot+amputation+prevention&rft.inventor=PUPO+ESCALONA+ELDER&rft.inventor=BETANCOURT+RODRIQUEZ+BLAS+YAMIR&rft.inventor=BERLANGA+ACOSTA+JORGE+AMADOR&rft.inventor=PAEZ+MEIRELES+ROLANDO&rft.date=2015-05-20&rft.externalDBID=A&rft.externalDocID=CN104623632A |